Skip to main content
Clinical Trials/JPRN-UMIN000011105
JPRN-UMIN000011105Completed未知

Virological efficacy and safety of telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis - Telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis

The Kyushu University Liver Disease Study (KULDS) Group0 sites150 target enrollmentStarted: July 3, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
150

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Positivity for antibody to human immunodeficiency virus or positivity for hepatitis B surface antigen Hepatic decompensation (Child B or C) Excessive active alcohol consumption

Investigators

Sponsor
The Kyushu University Liver Disease Study (KULDS) Group

Similar Trials